173 related articles for article (PubMed ID: 30239239)
1. Efficacy of Intravitreal Dexamethasone Implant in Patients of Uveitis Undergoing Cataract Surgery.
Gupta G; Ram J; Gupta V; Singh R; Bansal R; Gupta PC; Gupta A
Ocul Immunol Inflamm; 2019; 27(8):1330-1338. PubMed ID: 30239239
[No Abstract] [Full Text] [Related]
2. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
Larochelle MB; Smith J; Dacey MS
Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative dexamethasone implant in uveitis patients with cataract undergoing phacoemulsification.
Gupta A; Ram J; Gupta A; Gupta V
Ocul Immunol Inflamm; 2013 Dec; 21(6):462-7. PubMed ID: 23941542
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis.
Jinagal J; Gupta G; Agarwal A; Aggarwal K; Akella M; Gupta V; Suri D; Gupta A; Singh S; Ram J
Indian J Ophthalmol; 2019 Jan; 67(1):69-74. PubMed ID: 30574896
[TBL] [Abstract][Full Text] [Related]
5. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract.
Ren Y; Du S; Zheng D; Shi Y; Pan L; Yan H
BMC Ophthalmol; 2021 Jun; 21(1):245. PubMed ID: 34088282
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
[TBL] [Abstract][Full Text] [Related]
9. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
Nobre-Cardoso J; Champion E; Darugar A; Fel A; Lehoang P; Bodaghi B
Ocul Immunol Inflamm; 2017 Aug; 25(4):447-454. PubMed ID: 27003221
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Dexamethasone Implants in Uveitic Macular Edema in Cases with Behçet Disease.
Yalcinbayir O; Caliskan E; Ucan Gunduz G; Gelisken O; Kaderli B; Yucel AA
Ophthalmologica; 2019; 241(4):190-194. PubMed ID: 30244248
[TBL] [Abstract][Full Text] [Related]
12. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
Khurana RN; Porco TC
Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal injection versus systematic treatment in patients with uveitis undergoing cataract surgery: a systematic review and meta-analysis.
Hsieh YH; Jhou HJ; Chen PH; Hwang YS
Graefes Arch Clin Exp Ophthalmol; 2023 Mar; 261(3):809-820. PubMed ID: 36271933
[TBL] [Abstract][Full Text] [Related]
14. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
15. Repositioning and follow-up of intralenticular dexamethasone implant.
Munteanu M; Rosca C
J Cataract Refract Surg; 2013 Aug; 39(8):1271-4. PubMed ID: 23889870
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of a Dexamethasone Implant for the Treatment of Refractory Cystoid Macular Oedema in Non-Infectious Uveitis].
Breitbach M; Rack D; Dietzel M; Heinz C; Heiligenhaus A
Klin Monbl Augenheilkd; 2016 May; 233(5):601-5. PubMed ID: 27187880
[TBL] [Abstract][Full Text] [Related]
18. Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema.
Bansal P; Agarwal A; Gupta V; Singh R; Gupta A
Indian J Ophthalmol; 2015 May; 63(5):416-22. PubMed ID: 26139803
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification.
Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
Eur J Ophthalmol; 2014; 24(3):387-91. PubMed ID: 24170523
[TBL] [Abstract][Full Text] [Related]
20. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.
Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR
Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
